ࡱ> egd)` Rc.bjbjb{{ '  RRR8L, ,"000,,,,,,,$/hK2f*,Q "*, 00{,F 0 0,,' (0 h6MRG'+,<,'2| 3$((242$ (D"@Xl*,*,KX,   DR   R    Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.q\qge兡N gPlQSShandong Xinhua Pharmaceutical Company Limiteda joint stock company established in the People s Republic of China with limited liability Stock Code0719 VOLUNTARY ANNOUNCEMENTThe Board of Shandong Xinhua Pharmaceutical Co., Ltd. (the  Company), by taking into account of the actual circumstance of the Company, and based on its confidence it has in the prospect of the future development of the Company, the recognition of the Companys value and in order to promote the continuous, stable and healthy development of the Company while safeguarding the interests of the shareholders as a whole, has formulated the following plan: To actively procure the major shareholder of the Company to comply with the relevant requirements stipulated under the announcement (CSRC Announcement) issued by the China Securities Regulatory Commission (CSRC) [2015] No. 18, namely, not to reduce its holding of the Companys A shares within 6 six months from the date of the issuance of the CSRC Announcement;To closely adhere to the spirit of the Notice on the Relevant Matters relating to Increasing of the Holding of the Shares of a Listed Company by its Substantial Shareholders, Directors, Supervisors and Senior Management ( 0ܕe N^lQS'YqgScN0vNTؚ}{tNTXc,glQShyvܕNvw 0) by encouraging the directors, supervisors and senior management members of the Company to increase their holdings of the Company s A shares;The Company will continue to make advancements in relation to its scientific research and product production, focus on its scientific and technology innovation, make product structure adjustments and production upgrade, devote more resources to expand sales channels for its products and improve product quality, so as to reduce costs and to establish a long-term investment mechanism for its investors to help continuously improve the investors return on their investments in the Company; andTo make all efforts to communicate with the investors, to maintain the image of the p q r s   v x z . 0 2 4 H J R T īoe_eoQoeoAoh7^B*KHPJnHph# tHh7^B*KHnHph# tH h7^KHh7^B*KHph# &h7^B*KHPJ^JnHo(ph# tH)h7^5B*CJKHPJ\nHph# tH%h7^5B*CJKH\nHph# tH0h7^5B*CJKHPJ\^JnHo(ph# tH!h7^5B*CJKHOJ\ph# "h7^B*CJKHOJaJo(ph# jh7^UmHnHu h7^5o(h7^q s t  x 2 V X sL & FdEƀWl7'.gdxRdgdew $d1$a$gd]($7$8$H$XD2a$$>7$8$H$XDa$ $7$8$H$a$7$8$H$;.b.T V X  ( L M ^ h o p w -69KNOƯzztzkkzeezk h)CJh{hO%CJ hO%CJhO%CJo( hxRCJh"h"CJhO%h"5CJ hHCJh{h](CJ h"CJ,h](5CJKHOJQJ\^JaJmH sH ,h=j5CJKHOJQJ\^JaJmH sH ,hH5CJKHOJQJ\^JaJmH sH h7^B*KHo(ph# 'O[f$&4[\^bder{hxRhxRCJh05QCJo( h)CJhxRh](5CJ hewCJhxRhxR5CJh{hxRCJh{hewCJ h](CJhVCJo( hxRCJhO%CJo(h{h](CJ9jl]L & FdEƀWl7'.gd!L & FdEƀWl7'.gdxRdgdew $%/034<=DOPQbcpqwx{|}~*LNPl귭׷͡áÕhVB*CJph%%%hVB*CJo(ph%%%h!B*CJo(ph%%%h](B*CJph%%%h](B*CJo(ph%%%h!B*CJph%%%h]j B*CJph%%%h{h!B*CJph%%% h!CJh{h](B*CJph%%%h{h)CJ6 02:PRTVZfhjl$ŹܢiUiAUAUAA'hVB*CJfHo(ph333q 'h05QB*CJfHo(ph333q *h{h05QB*CJfHph333q *h{h](B*CJfHph333q h{h]j B*CJph%%%h](B*CJph%%%h{h05QB*CJph%%%hVB*CJo(ph%%%hVB*CJph%%%h{hVB*CJph%%%h05QB*CJo(ph%%%h{h](B*CJph%%%h]j B*CJph%%%$)*-016;<WZ[dxyïoooo\\Oïooïïh!hLB*CJph%%%$h{kB*CJfHph333q 'hVB*CJfHo(ph333q *h{hVB*CJfHph333q *h{h05QB*CJfHph333q 'h05QB*CJfHo(ph333q *h{h](B*CJfHph333q 'h](B*CJfHo(ph333q $h](B*CJfHph333q   !GHPSjstտ뿗n[H$h](B*CJfHph333q $hO%B*CJfHph333q $h{kB*CJfHph333q *h{hO%B*CJfHph333q 'hO%B*CJfHo(ph333q 'h05QB*CJfHo(ph333q *h{h](B*CJfHph333q *h{hVB*CJfHph333q 'hVB*CJfHo(ph333q , ,,0,1,I,O,P,Q,R,ԨkU?. h=5CJKH\aJmH sH *h{kh=B*CJfHph333q *h{h05QB*CJfHph333q 'h05QB*CJfHo(ph333q *h05Qh05QB*CJfHph333q $h{kB*CJfHph333q U*h{hO%B*CJfHph333q 'hO%B*CJfHo(ph333q *h{h](B*CJfHph333q *h{h{kB*CJfHph333q Company and to strive to increase the confidence of the investors in the market. By Order of the BoardShandong Xinhua Pharmaceutical Company LimitedZhang DaimingChairman13 July 2015, Zibo, PRCAs at the date of this announcement, the Board comprises:Executive Directors: Independent Non-executive Directors:Mr. Zhang Daiming (Chairman) Mr. Du GuanhuaMr. Du Deping Mr. Li Wenming Mr. Chan Chung Kik, LewisNon-executive Directors:Mr. Ren FulongMr. Xu LieMr. Zhao BinPAGE PAGE 1Q,R,,,,,,,-p]SSS XD2YD2dh1$WD]`gdj dh1$WD ]`gdh$dh1$`a$$dh1$]`a$dh1$XD2YD2gd=L & FdEƀWl7'.gdO% R,,,,,,,- -----------:.;.<.>.?.A.B.D.E.G.I.J.P.Q.R.T.U.[.\.].^._.a.b.c.µµ~~~s~h?)V0JmHnHu h(A0Jjh(A0JUh(AhVjhVUh/gUh/gUCJKHaJh'i~CJKHaJhhh7^CJKHaJh/gUCJKHaJh]CJaJh05QCJaJo(hhh7^6CJaJhhh7^5CJaJhhh7^CJaJ+- -m-n---.".-.:.;.=.>.@.A.C.D.F.G.H.I.R.S.T.&`#$ &dPdh1$XD2YD2`gd/gU $7$8$H$a$T._.`.a.b.c.dh1$XD2YD2`gd/gU&`#$0182P. A!"#$%S nu*l?xK-PNG  IHDRryJzgAMA pHYsLLXtcPLTE#$ 84*&'"51;7.*?;2-2./+40)%(#,(=9950,+'=83.627383B>B?A=C?@=QNUQNJFBJFXU\Y^[DAZWIF]ZOKHDWSQMMJKHSOD@YUVSLISPFCYV[W^ZROLHOLWTb_`\a^b^`]iftrfc}pn|ymjxupmvtywc`li~{}{wt}{rogdvsda~{xuebnkkgkholtqheqnpnspzw{x~}ƵG'IDATx}|yNg˲$Dz6d[r^ 8&!iP*`Ԙ˒lbh^ZQ@!M#'MI4mt/kvӦMO$nwvgyfgwgt7<3(Z8˱!}t%O_dKU}*meDW܇lL7{]+>IcMC|l4IzO̚*Irìi.! gKz8T*%,佫X ˏ<&K$]vUtɑ,VEzIyH.#Ϛ!tifPIѳf$]Nfx$]F䜳fX$]>.fpHl]Κatg&o#K>k.8ietgƾUFI9|֌4&(D2I$ʴ[K\Co~$]YgȎ*FC$A#eY/c#"OFj+ <#۠1kZǮWM?f5$=Y!R+K.>k*qبPެM`$oY _&I1k̊/ 6/~"G̚J]Y͠E-%B$cJME.s`SϒrĬ9ö"^}2JOfdGʶ*Fwt%YSYw-V21 1y oU2l"lJK=G5ڠ}>i&{1kF%03%)Iy?|Tjzώ|vK{Áw돳L&)sI:i<";ZKܔ{< 5$1FT=twLW|^2? 6{) _%R;I1fI~3Dv F)+I3kFf4b[jNv)I3k* 5lc557{"bcfMsWz_&[lJ@E"̚ K,iM%]r̬IUlr̙p +颐cfM ߽٨Ɇ7t1QQai˿.9fdUll)] @5mB*ëN* tQ~͗26w_pS Iw5km{ޕCL3u B]!G͚,6gt9fִ: qsѪ”%(Y(iD TW#fMA$)/pY AA8z=CfMQ`J/{]MYS:Naq&(D08J;0tCfMQ@ "4\ҝfȶsidz?t;"G͚DtGaJJrܬs"paL IE5yBRlLB ͚.BSl鱊1;K;O9kz~"bsz s[QG#gMe~6iDjcLI!GΚ~ؤS\m%]Κ~$N#)}BܬQ`]j]|sa\Q#y0Y >/ <ʔ>&FzQœt/8EXlFt<ʔ_k=+= 071ox ɕpAqQj] *>~.6Q,tzM (Q_6\#frRLQB]uIRvpzM eۣ|mwJ63;VVX RԣLQ']iѧ3O޵ˍznq(ybE>)ΉFIX88S:U ,U3sdθT`"NBBonaEBORVV+x2j ' s%NR08E=ƓGVhbf#i+zbiӪ8SR"DKnb5rSWMu;6rH[!V#3S0Ow.Bd.A#[̕`XPg #ȂE#/93fZeɌ\S{<03Ol#4 2)J{d<=`[Sԗ ˀ\S%-x,-|@u=݅}55FJ77(\dcs'`}IIFKgnFmNڳw8B?Hz,s-ډ-}ֽ-V,a \954O|\*Kѹ\nW"ZO_^6MSa&y <07t|-s<7{<2*C6m,^YZ=@9Q(iE0b+ANlzQ~O9Q_\jVv^X !*y{F0DiR#ϲӓO5||@c|ȋA^Ɍ=t*"GIgPݙ-M> 9RP86uimڰJsp>/;|(|=i :\2noi@ Wߍ}kj qg@>a19i?K]~되>>7xlgߗ@g sh.~K|~ xs>"¹7U­Ůһ4vvg^i4so8xgkSdpG+'rmS}̈́ð)wh39jkku?ʒa@VfN6:%BwSTjc9u h5#p%k _=ANWvm)eͯlW+RuKw)]zYv})K-_%)kxb[nZ TVdxN~Uwjb;? bPVWȵ!|,<}qP ~9kZgL/g}lIV6z tNyPw\ܵ!1[gtwA[h%#N0y@d z|+C ŕ5G.Yn1<'`MMM7}dy(B#,yKg\7S;w²n r<0w :ҹ0)oux9֖~e⯖gs4[_Sۿ[ rf;G^8}EO{뢂G\Y/XId(Wp=Lh+ve7(so+}Gi'Mp_kk'KD74mфG-1 >cUƱe9 +5?r/:i@~D Gu݅fIZ`UEN 'D%=u\ 3A~ YoaEٷs7Dޠ_E8@-J1|s )rOAO.мE%!185<Ӧi_r`/qc/*!wR?̱+[=aǎ0{̱~}ee];Mf-nz1_W<o5O_cc>YF3>xפ@r.GΏcM]G}EuT)My+78ϻﵱ7Wa=U=_sYjr uK7xCuQ_?Yf n% ؜G-Y`n9 R9؆۳˔F„܀?mG^ {:Fߘ2C7CTk=\@pFk}j&'jv r5qC[:+@ުv߈MarCij BNԓ~P-w9j| 4E"G9 eljUc9!~sS̊PSFF:"YeSC\yHf GL2;6h3c&TiWyf|;tk$o59Yh{w{QȉJN,tΐH#\2*ّ$ʥ ~G0M}"'߇ǽ#FCx#;]vkr"']yVjMN\wn^ZǡWZ#Oo3w,J1G%EBOM_!X#ׯͦۡ"'rLQ5r})mx }M(%r3>QH}/yfN^܌ur"ȹOf5Z.\F|ߩch !~ kn*e#7vReUS8%!G~e`[pCheeAUsn+dz.~#GF3ܟ 9fu<' tW:H<:Kg I;N]:֜op?vԼ,Bkm܍VE8'w c$a_SPTVn58pi.7Ȋ|֜N)meX>wK*)07f^xz)G4w0oVjtP\RQ^so= PկMAwoIң_:û]ul#t0tHq}g:v.;'ѻ\^Vz9WʽRm5ݪ~yv N}Y!Pr&lj&(9f4@k|9!KE\oEqo*<#Z8kcu#QMe"w,:p/ė%"'W+S3'rN"Cr{\]^-P:~pOqL /r[+:@0#ֳ!9bb0,~[;|oB-l$rS't| !G4>ޱ ANg\RSVtDåZ-rTuif=˿1ȭ$K!O8f;`ŽsݦFvzozpWލ+++^=aG>@W2۱ή^=":۷{Eeu}sǂX>h#'Jg 3'U y>K ;rMyUQ v77- ?r*3arCޛ}u7^=n^n7]Vjz~T,PT|' %zo^ IL]" *^e6rg2OCy|l oPVmR rK?1f>B7pvk^77eT$r*gFE/AFj69iF= )N75u cy~iFƧ s|n14#kꑎ,EwA"^(m<x$|Drn=2P Wʻ Sp J<񉲋Jܔ3U=F/5>JtM"@4j|:@ !,rE/*քU5lώU}Mmy=wMu%{nA܇+ߒnzkݼhMBt#`+iyWw T?%EeM}'jӖb76f5`D<$Z $}7uQdk"%Z CrŃ⏤79#㦪5ǥDxOQEWaTnePu}?L(*hc^*R^QbEP/{ |%.#;f?d ?iKz $"l+is=x(J|kc.85`(hJ(l_sY^c%NQHiЕĶXĻCY#+=raDF+CBb~X?ĉx >< ptAwEԜӇjZRI7f. qmZ8CbeA!x%%p/ =K5Q$ݴkG\#^UC6I7rfU;o6n^6 _)ꊝeml 1vi,w.x4̉J.8IoIýlw'kmb JSQ>c釐<7 HһGGZSKG{WD{s{i\^6 <$=ߍq3htcS<W} 4|lMbϛvU*=8N1g,3{6]"Iqԋ[$|V'[g 4rgrH:X^6rWoqH8*n+t0E}hW f%&PQ U籤CE<L%.Iq`JmDCB666666666666666666666666666666666666666666666666hH666666666666666666666666666666666666666666666666666666666666666666J@J cke $1$a$ CJKH_HaJmH nHsH tHT@T 'Ph 1$<@&"5CJ KH OJPJQJ\^JaJ F@F $%h 3$ & Fdp@&5CJ\aJL@L %%h 5$ & Fdp@&5B*CJ\ph$A@$ ؞k=W[SOFiF 0nfh*ph+++4O4 smallsize1CJaJ2O!2 line31CJaJphfff0O10 bigsize1CJaJ*OA* cmt1 <.OQ. print1 <2Oa2 forword1 <$Oq$ agreen(O( down7ph3t.@. yblFhe,gCJaJ< @< u$9r G$a$CJaJ)@ uxN@N u w'$9r &dG$Pa$CJaJ<O< tw4winMark<B* H*phrOrChar Char Char Char$d1$a$CJKHaJmHnHtHu<B@< ckee,g1$6PJaJnHtHhOh Default 1$7$8$H$1B*CJOJPJ^J_HaJmH nHphsH tH\\ @CQ>[[0 0 p p      9 < e k t q t   /  !/"aDZ`)PH!jb>yRk~i:$y6 zh t^t`hH.h D^D`hH.h  L^ `LhH.h  ^ `hH.h ^`hH.h L^`LhH.h T^T`hH.h $^$`hH.h L^`LhH.$^$`5OJ QJ ^J o(() ^`hH. L^`LhH. | ^| `hH. L^L`hH. L^`LhH. ^`hH. ^`hH. L^`LhH. ^` . ^` PJ o(() ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` .h80^8`0o(hH()h ^`hH.h pL^p`LhH.h @ ^@ `hH.h ^`hH.h L^`LhH.h ^`hH.h ^`hH.h PL^P`LhH.h h^h`hH.h 8^8`hH.h L^`LhH.h  ^ `hH.h  ^ `hH.h xL^x`LhH.h H^H`hH.h ^`hH.h L^`LhH.80^8`0OJPJQJ^Jo(. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.!/"`):$y!jPH!/"yRk                 FCؿ       i                 ؎        iLj '^7wR*Q,g{CY O+d>@I!V+x @CQmHK*-U]j __!z"~#,$O%n&W&'p'zt(*k+-,,/S0273n4-6=Y6A>7^89rO9'g;=~=IL>BrB{3FMGSIJJK0^KDO05QU=SgT MUTU/gU?)VfGXKY9Z7|Zb]7^(5^_G_/`Cv`x>a0eL3f=ifDij+j-j{k&~k"qnqt]w!=x[ +~C/LHp ROI FXdj"&.>xR5JXs$)>$V{=jj0PDYRt3M@bQ(n'` ~{6=HL4j&k`)(;zV&hOwn6Yu(AEqT]:#';-y](C&h% w K@ssdssLttPPJ P@P P@PP$@PX@UnknownhggSf Gz Times New Roman5Symbol3& z Arial;[SOSimSunC .PMingLiUe0}fԚgTimesLTStd-BoldTimes New Roman7K@CambriaKPMCHM I+ Times[SO7&  VerdanaiTimesLTStd-RomanTimes New RomanI Arial Unicode MS 1eWl7'k7'=  -!),.:;?]}    & 6"0000 0 000000 =@\]^([{  0 0 00000;[d  JqHX $P"q2Rider Katherine CARRIECHENGhggSfMO & i Z'`IZ'$      Oh+'0|   , 8 DP\dltRider Katherine  CARRIECHENGNormal23Microsoft Office Word@U@l>@&@2M ՜.+,0 X`t|  my company '   !"#$%&'()*+,-./013456789;<=>?@ABCDEFGHIJKLMNOPQRSUVWXYZ[]^_`abcfRoot Entry Fh6MhData 21Table:-3WordDocumentbSummaryInformation(TDocumentSummaryInformation8\CompObjm  FMicrosoft Office Word ĵ MSWordDocWord.Document.89q